Physician profile
John Manicone
NPI 1518967249
$1,048.56
in general payments reported to CMS, 2019-2025
18 companies · $305 in 2025
The $305 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $101 · 2020: $11.61 · 2021: $56.39 · 2022: $224 · 2023: $224 · 2024: $126 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $160.48 | 2021-2023 | Arista Ah Flexitip |
| Convatec INC. | $129.25 | 2023-2025 | |
| Organogenesis INC. | $125.00 | 2022 | |
| Smith+Nephew, INC. | $113.91 | 2019-2025 | Collagenase Santyl, Regranex |
| Lifenet Health | $89.03 | 2025 | Theragenesis Wound Matrix |
| Medtronic, INC. | $72.83 | 2022-2024 | Progrip |
| Solventum Corporation | $52.19 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C.Instill |
| Avanos Medical | $48.61 | 2019-2024 | Initial Placement Kits |
| Kci USA, INC. | $48.42 | 2021-2022 | |
| Next Science LLC | $46.72 | 2022-2023 | Xperience, Blastx, Surgx |
| Integra Lifesciences Corporation | $35.49 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $24.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hartmann USA, INC. | $22.47 | 2025 | Zetuvit Plus 10x10 P10 |
| Bioventus LLC | $19.64 | 2019 | |
| Acell, INC. | $17.20 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $16.70 | 2021 | |
| Intra-Sana Laboratories | $13.49 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Pacira Pharmaceuticals Incorporated | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Manicone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.